Literature DB >> 9306050

Safety issues in the use of methylphenidate. An American perspective.

M D Rappley1.   

Abstract

Methylphenidate is the most widely use psychotropic medication in children in the US. It is both well tolerated and efficacious in the treatment of attention deficit hyperactivity disorder, and is associated with few serious adverse effects. However, the abuse of methylphenidate for the purpose of experiencing a 'high' is hazardous. The use of methylphenidate in combination with other medications increases the risk of adverse effects and drug interactions. Good communication between the physician, patient and family, together with monitoring, increases the likelihood that methylphenidate therapy will be effective and have no adverse consequences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306050     DOI: 10.2165/00002018-199717030-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  38 in total

1.  Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.

Authors:  R A Barkley; M B McMurray; C S Edelbrock; K Robbins
Journal:  Pediatrics       Date:  1990-08       Impact factor: 7.124

2.  Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report.

Authors:  S L Kaplan; J Busner; S Kupietz; E Wassermann; B Segal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1990-09       Impact factor: 8.829

3.  Clonidine and sudden death.

Authors:  M J Maloney; J S Schwam
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

4.  Side effects of methylphenidate and desipramine alone and in combination in children.

Authors:  C S Pataki; G A Carlson; K L Kelly; M D Rapport; T M Biancaniello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-09       Impact factor: 8.829

5.  Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.

Authors:  T E Wilens; T Spencer; J Biederman; J Wozniak; D Connor
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-01       Impact factor: 8.829

6.  Perseveration induced by methylphenidate in children: preliminary findings.

Authors:  I Z Dyme; B J Sahakian; B E Golinko; E F Rabe
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

7.  Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height.

Authors:  R G Klein; S Mannuzza
Journal:  Arch Gen Psychiatry       Date:  1988-12

Review 8.  Attention deficit disorder: a review of the past 10 years.

Authors:  D P Cantwell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-08       Impact factor: 8.829

9.  Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

Authors:  V Gross-Tsur; O Manor; J van der Meere; A Joseph; R S Shalev
Journal:  J Pediatr       Date:  1997-01       Impact factor: 4.406

10.  IV pentazocine/methylphenidate abuse--the clinical toxicity of another Ts and blues combination.

Authors:  H S Carter; W A Watson
Journal:  J Toxicol Clin Toxicol       Date:  1994
View more
  8 in total

Review 1.  Misuse of stimulant medication among college students: a comprehensive review and meta-analysis.

Authors:  Kari Benson; Kate Flory; Kathryn L Humphreys; Steve S Lee
Journal:  Clin Child Fam Psychol Rev       Date:  2015-03

Review 2.  Extended-release methylphenidate (Ritalin LA).

Authors:  Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Assessing methylphenidate preference in ADHD patients using a choice procedure.

Authors:  Emily MacDonald Fredericks; Scott H Kollins
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

4.  Methylphenidate Abuse and Psychiatric Side Effects.

Authors:  W Alexander Morton; Gwendolyn G. Stockton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

Review 5.  Dexmethylphenidate.

Authors:  Gillian M Keating; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Comorbidities in ADHD children treated with methylphenidate: a database study.

Authors:  Angela A Kraut; Ingo Langner; Christina Lindemann; Tobias Banaschewski; Ulrike Petermann; Franz Petermann; Rafael T Mikolajczyk; Edeltraut Garbe
Journal:  BMC Psychiatry       Date:  2013-01-07       Impact factor: 3.630

7.  Methylphenidate and suicidal ideation: Report of two cases.

Authors:  Priti Arun; Sukhtej Sahni
Journal:  Indian J Psychiatry       Date:  2014-01       Impact factor: 1.759

Review 8.  From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.

Authors:  Francesco Paolo Busardò; Chrystalla Kyriakou; Luigi Cipolloni; Simona Zaami; Paola Frati
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.